Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.
Sanja StanojevicStephanie D DavisGeorge Retsch-BogartHailey WebsterMiriam DavisRobin C JohnsonRenee JensenMaria Ester PizarroMica KaneCharles C ClemLeah SchornickPadmaja SubbaraoFelix A RatjenPublished in: American journal of respiratory and critical care medicine (2017)
LCI is a useful marker to track early disease progression and may serve as a tool to guide therapies in young patients with CF.